3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
SMD Rise PCL's 3-Year ROIIC % for the quarter that ended in Dec. 2025 was -61.56%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for SMD Rise PCL's 3-Year ROIIC % or its related term are showing as below:
BKK:SMD100-R's 3-Year ROIIC % is ranked worse than 87.61% of 113
companies
in the Medical Distribution industry
Industry Median: 2.2
vs BKK:SMD100-R: -61.56
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
SMD Rise PCL 3-Year ROIIC % Related Terms
SMD Rise PCL 3-Year ROIIC % Historical Data
* Premium members only.
The historical data trend for SMD Rise PCL's 3-Year ROIIC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BKK:SMD100-R vs MCK, CAH, COR: 3-Year ROIIC % Comparison
For the Medical Distribution subindustry, SMD Rise PCL's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SMD Rise PCL 3-Year ROIIC % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, SMD Rise PCL's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where SMD Rise PCL's 3-Year ROIIC % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
SMD Rise PCL (BKK:SMD100-R) has a 3-Year ROIIC % of -61.56 as of Dec. 2025. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on SMD Rise PCL and its competitors. According to the industry distribution chart, SMD Rise PCL ranks #99 out of 113 companies in the Medical Distribution industry, placing it in the top 87.6%.
Is SMD Rise PCL's 3-Year ROIIC % too high?
SMD Rise PCL's current 3-Year ROIIC % is -61.56. Based on the distribution chart, SMD Rise PCL ranks #99 out of 113 companies in the Medical Distribution industry, which is in the bottom quartile relative to peers. Overall, SMD Rise PCL has a GF Score™ of 59/100, reflecting its overall financial health beyond just this single metric.
How does SMD Rise PCL's 3-Year ROIIC % compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, SMD Rise PCL ranks #99 out of 113 companies for 3-Year ROIIC %. This places SMD Rise PCL in the lower half of its industry. The industry median 3-Year ROIIC % is 2.20. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Medical Distribution company?
The median 3-Year ROIIC % among Medical Distribution companies is 2.20, based on 113 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on SMD Rise PCL and its competitors. For the Medical Distribution industry, the median 3-Year ROIIC % is 2.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. SMD Rise PCL's current 3-Year ROIIC % is -61.56. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SMD Rise PCL stock overvalued right now?
SMD Rise PCL (BKK:SMD100-R) has a current 3-Year ROIIC % of -61.56. The stock's GF Value™ is ฿24.66, compared to a current price of ฿5.85 — trading 76.3% below its estimated fair value. The current 3-Year ROIIC % is -61.56. SMD Rise PCL's overall GF Score™ is 59/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For SMD Rise PCL (BKK:SMD100-R), the current 3-Year ROIIC % is -61.56 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is SMD Rise PCL (BKK:SMD100-R) Overvalued in 2026?
Based on GuruFocus' analysis, SMD Rise PCL stock appears to be undervalued.
The current stock price of ฿5.85 is trading 76.3% below its estimated GF Value™ of ฿24.66.
Key valuation signals for BKK:SMD100-R:
3-Year ROIIC %: -61.56
GF Value™: ฿24.66 vs. price of ฿5.85 (76.3% below fair value)
No single metric tells the full story. See the BKK:SMD100-R stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Address222,222/1-2 Moo 1, Rattanathibet Road, West Inn Complex Building, 10th Floor, Bang Rak Yai Subdistrict, Bang Bua Thong District, Nonthaburi Province, Bangkok, THA, 11110
SMD Rise PCL, formerly Saintmed PCL is engaged in the import and distribution of medical devices and equipment, rental services for medical equipment, and providing services related to medical equipment. It operates in Thailand. The Group is engaged in three operating segments: Sale of medical devices and equipment, medical supplies, Services of medical equipment at sleep lab centers and repair services, and Revenue from rental of medical equipment at wellness centers and other services. The Group is managed and operates principally in Thailand.
59GF Score
Get the complete analysis for BKK:SMD100-R
3-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:SMD100-R has been successfully added to your 
